# KET-RO Plus RO DBT for Treatment Resistant Depression

> **NCT06138691** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 16 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **COMBINATION_PRODUCT:** Ketamine Infusion plus RO DBT

## Key facts

- **NCT ID:** NCT06138691
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-04
- **Primary completion:** 2025-01-11
- **Final completion:** 2025-02-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06138691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06138691, "KET-RO Plus RO DBT for Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06138691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*